Enchondroma Pathology
Updated: Dec 30, 2020
Author: Lorenzo Gitto, MD; Chief Editor: O Hans Iwenofu, MD, FCAP
Definition
Enchondromas are benign, intramedullary, usually solitary cartilaginous neoplasms that predominantly grow in the metaphyseal portion of tubular bones. They arise from foci of displaced or remodeling cartilage of the growth plate. Chondrocytes start proliferating during childhood, leading to enlargement of the tumor. In adulthood, enchondromas usually stop growing but persist.
Multiple enchondromas (enchondromatosis) are typically seen in Ollier disease and Maffucci syndrome.[1] Ollier disease features multiple intraosseous enchondromas with variable numbers, sizes, and locations.[2] Maffucci syndrome is characterized by multiple enchondromas and extraosseous hemangiomas.[3] Ollier disease and Maffucci syndrome are typically not inherited; however, there are exceedingly rare subtypes of enchondromatosis that show autosomal dominant and recessive inheritance.
Enchondromas are relatively common lesions, accounting for up to a quarter of benign bone tumors and roughly 10% of all bone tumors. They may present at any decade of life, but more than half of cases occur between the second and fourth decades of life with an equal sex distribution.[4, 5, 6]
Etiology
The exact etiology of enchondromas remains unknown. The lesions can be described as masses of hyaline cartilage in a lobular pattern resulting from growth plate remnants that are not resorbed, and they either persist or begin to grow in the medullary canal.[4] The vast majority of enchondromas occur in the medullary portion of the diaphysis or metaphysis, and they expand toward the cortex, sometimes producing bone weakness and pathologic fractures.
In both solitary and syndromic enchondromas, frequent gain of function mutations in the isocitrate dehydrogenase-1 and -2 (IDH1 and IDH2) genes are observed.[7] IDH1 and IDH2 encode isocitrate dehydrogenase enzymes that ultimately lead to inhibition of osteogenic differentiation. Additionally, chondrocyte-specific deletion of fibroblast growth factor receptor 3 (FGFR3) induces multiple chondroma-like lesions, including enchondromas and osteochondromas, adjacent to disordered growth plates.[8]
Location
Enchondromas have a distinct predilection for the appendicular skeleton.[9] The most frequently involved location is the hand, with the proximal phalanx being the most commonly involved site.[10] Less often enchondromas involve the feet, followed by the long tubular bones.[11] The proximal or distal femur and the proximal humerus are the most commonly involved long tubular bone sites.[12] Enchondroma of the spine, pelvis, and ribs are uncommon.[13, 14] A case of a rare enchondroma arising in the mandibular body has been reported in the literature.[15]
Clinical Features and Differential Diagnosis
Enchondromas are often discovered incidentally and are not usually painful. When they occur on the extremities, they can present with swelling and as a palpable mass. If pain is present, it probably correlates with growth activity. Sometimes, the presenting sign of of these tumors is a pathologic fracture.
The distinction between enchondroma and low-grade chondrosarcoma is especially pertinent when the lesion involves the long bones. A painful lesion, with histology showing myxoid change, hypercellularity, and atypia would all point to a diagnosis of chondrosarcoma.[9]
Imaging Studies
Initially, radiography is the imaging modality of choice for suspected enchondromas. On x-rays, they appear as lytic lesions with scalloped borders, predominantly lucent with internal mineralization.[16, 17] The calcified foci vary from powderlike to dense aggregates. This mineralization is a result of the endochondral ossification that accompanies these tumors.
Enchondroma Pathology. Plain radiographs will reveal lytic lesions with scalloped borders. When internal matrix is present, it is arranged in arc and ring or stippled patterns. A fracture can be associated with the lesion, especially in the small bones of the hands and feet.
If further characterization is necessary, magnetic resonance imaging (MRI) or computed tomography (CT) scanning is performed. If uncertainty remains, bone scanning may be helpful, but some lesions require biopsy. Enchondromas may be located centrally, eccentrically, or they may occasionally be multicentric. In large tubular bones, enchondromas produce little if any endosteal cortical erosion, and if endosteal scalloping is present that is more than two thirds of the cortical thickness, a diagnosis of chondrosarcoma must be considered.
CT scans can help reveal the internal matrix production in the form of rings and arcs, which correspond to calcification around lobules of cartilage.
MRI shows lobulated borders with a cluster of numerous tiny locules of high-signal-intensity foci on T2-weighted images that appear to coalesce with one another and reflect the high fluid content of hyaline cartilage. MRI can also be useful to distinguish enchondromas from bone infarcts. [18]
See the Medscape Drugs and Diseases article Enchondroma and Enchondromatosis Imaging for additional information on this topic.
Gross Findings
Most enchondromas are treated by curettage, and resected specimens are rare. The curetted material presents as confluent masses of grayish-blue and glistening hyaline cartilage with a distinct lobular arrangement. In the rare instances in which an enchondroma is received intact, the cartilage tissue is usually clearly noticeable on gross examination. The lesion is characterized by confluent lobules of cartilage, and the periphery of the lesion is frequently irregular. Calcifications seen on imaging may be confirmed at gross examination of the specimen.
Microscopic Findings
The microscopic appearance of enchondromas may vary based on their anatomic location, which should always be considered before describing the lesion histologically. The enchondroma is composed of well-circumscribed lobules of benign hyaline cartilage. Lobules can be completely or partially separated by interposed bone marrow spaces or fibrovascular septa. Although uncommon, lobules can grow around the lamellar medullary bone, mimicking aggressive tumors such as chondrosarcoma with bone invasion.
The cellularity is typically low, and a few chondrocytes with small, dark, round regular nuclei with condensed chromatin are observed, usually located in lacunar spaces. Large chondrocytes with open nuclear chromatin or double/multinucleated cells can focally be present, but no atypia should be seen.
Fine-purple irregular or granular calcifications can be observed. Foci of endochondral ossification may be present in heavily calcified enchondromas. Necrosis, myxoid change, and atypical mitoses are typically absent, and their presence should heighten suspicion for malignancy. However, enchondromas of the small bones of hands and feet may show myxoid change; these should be considered within the spectrum of changes observed in enchondromas of this location, as long as the findings are not diffuse. If there is a concomitant fracture, mitotic figures may be present as a result of the bone healing process.[19]
Cytology smears usually show thick hyaline cartilages, and it is hard to discern the cellular or lacunar outline. Fluid and degenerated material and debris may be obtained as a result of the aspiration. The smear shows small round to oval chondrocytes, with small dark nuclei, no apparent nucleoli, and ill-defined cytoplasm embedded in the chondroid matrix. Double nucleated cells can rarely be focally seen, but no cytologic atypia should be present.[20, 21]
The following images depict histologic characteristics of enchondromas.
Enchondroma Pathology. Chondromas display large areas of basophilic extracellular cartilage matrix with broadly scattered bland chondrocytes.
Enchondroma Pathology. A focal increase in the cellularity of enchondromas can occur when they are traumatized or when an associated fracture is present. This is especially true of lesions in the hands and feet. Care should be taken not to diagnose these lesions as malignant based solely upon their cytology.
Enchondroma Pathology. Enchondromas can show endochondral ossification, and they are generally well demarcated from the surrounding marrow and trabecular bone.
Enchondroma Pathology. Myxoid degeneration can be seen in enchondromas in the hands and feet.
Immunohistochemistry and Ancillary Studies
Immunohistochemistry is not routinely used to evaluate enchondromas. Chondrocytes are positive for S-100 protein, vimentin, and SOX9 (a marker of cartilage differentiation). Cytogenetic studies have shown heterogeneous findings, and they may reveal aberrations, inversions, or translocations involving chromosomes 2, 6,12, 15, and 21.[22]
Prognosis and Predictive Factors
Most enchondromas are followed conservatively, but when treatment is indicated, they are treated by curettage, with or without bone grafting. Cartilage lesions are resistant to chemotherapy and radiotherapy, and these treatments are not used for enchondromas. The recurrence rate for curetted enchondromas is less than 5%, especially in areas of complicated anatomy.[23, 24]
Author
Lorenzo Gitto, MD Resident Physician, Department of Pathology, State University of New York Upstate Medical University
Lorenzo Gitto, MD is a member of the following medical societies: American Academy of Forensic Sciences, National Association of Medical Examiners
Disclosure: Nothing to disclose.
Coauthor(s)
Daniel J Zaccarini, MD Assistant Professor of Surgical Pathology, Department of Pathology, State University of New York Upstate Medical University
Daniel J Zaccarini, MD is a member of the following medical societies: American Medical Association, American Society for Clinical Pathology, College of American Pathologists, International Society of Urological Pathology, United States and Canadian Academy of Pathology
Disclosure: Nothing to disclose.
Chief Editor
O Hans Iwenofu, MD, FCAP Associate Professor (Clinical) of Pathology, Chief, Division of Soft Tissue and Bone Pathology, Department of Pathology, The Ohio State University College of Medicine
O Hans Iwenofu, MD, FCAP is a member of the following medical societies: American Society for Clinical Pathology, College of American Pathologists, Connective Tissue Oncology Society, International Skeletal Society, International Society of Bone and Soft Tissue Pathology, Ohio Society of Pathologists, United States and Canadian Academy of Pathology
Disclosure: Nothing to disclose.
Additional Contributors
Francis H Gannon, MD Associate Professor of Pathology and Orthopedic Surgery, Director of Residency and Fellowship Programs, Department of Pathology, Baylor College of Medicine; Staff Pathologist, Department of Pathology, Texas Children's Hospital, Ben Taub General Hospital and Debakey Veterans Affairs Medical Center
Francis H Gannon, MD is a member of the following medical societies: American Society for Bone and Mineral Research, International Academy of Pathology, International Skeletal Society, Texas Medical Association
Disclosure: Nothing to disclose.
Michael J Klein, MD Professor of Pathology and Laboratory Medicine, Weill Cornell Medical College; Pathologist-in-Chief, Director, Department of Pathology and Laboratory Medicine, Hospital for Special Surgery; Consultant in Orthopedic Pathology, Memorial Sloan-Kettering Cancer Center and Memorial Hospital for Cancer and Allied Diseases
Michael J Klein, MD is a member of the following medical societies: American Society for Clinical Pathology, College of American Pathologists, International Skeletal Society, United States and Canadian Academy of Pathology
Disclosure: Nothing to disclose.
El Abiad JM, Robbins SM, Cohen B, et al. Natural history of Ollier disease and Maffucci syndrome: patient survey and review of clinical literature. Am J Med Genet A. 2020 May. 182 (5):1093-103. [QxMD MEDLINE Link].
Jurik AG. Multiple hereditary exostoses and enchondromatosis. Best Pract Res Clin Rheumatol. 2020 Jun. 34 (3):101505. [QxMD MEDLINE Link].
Maione V, Stinco G, Errichetti E. Multiple enchondromas and skin angiomas: Maffucci syndrome. Lancet. 2016 Aug 27. 388 (10047):905. [QxMD MEDLINE Link]. [Full Text].
Hakim DN, Pelly T, Kulendran M, Caris JA. Benign tumours of the bone: a review. J Bone Oncol. 2015 Jun. 4 (2):37-41. [QxMD MEDLINE Link].
Akoh CC, Craig E, Troester AM, Miller BJ. Radiographic enchondroma surveillance: assessing clinical outcomes and costs effectiveness. Iowa Orthop J. 2019. 39 (1):185-93. [QxMD MEDLINE Link].
Mulligan ME. How to diagnose enchondroma, bone infarct, and chondrosarcoma. Curr Probl Diagn Radiol. 2019 May - Jun. 48 (3):262-73. [QxMD MEDLINE Link].
Bruce-Brand C, Govender D. Gene of the month: IDH1. J Clin Pathol. 2020 Oct. 73 (10):611-5. [QxMD MEDLINE Link].
Hallett SA, Ono W, Ono N. Growth plate chondrocytes: skeletal development, growth and beyond. Int J Mol Sci. 2019 Nov 29. 20 (23):542-7. [QxMD MEDLINE Link].
Ferrer-Santacreu EM, Ortiz-Cruz EJ, Diaz-Almiron M, Pozo Kreilinger JJ. Enchondroma versus chondrosarcoma in long bones of appendicular skeleton: clinical and radiological criteria-a follow-up. J Oncol. 2016. 2016:8262079. [QxMD MEDLINE Link].
Bachoura A, Rice IS, Lubahn AR, Lubahn JD. The surgical management of hand enchondroma without postcurettage void augmentation: authors' experience and a systematic review. Hand (N Y). 2015 Sep. 10 (3):461-71. [QxMD MEDLINE Link].
Chun KA, Stephanie S, Choi JY, Nam JH, Suh JS. Enchondroma of the Foot. J Foot Ankle Surg. 2015 Sep-Oct. 54 (5):836-9. [QxMD MEDLINE Link].
Lee DH, Hills JM, Jordanov MI, Jaffe KA. Common tumors and tumor-like lesions of the shoulder. J Am Acad Orthop Surg. 2019 Apr 1. 27 (7):236-45. [QxMD MEDLINE Link].
Guo J, Gao JZ, Guo LJ, Yin ZX, He EX. Large enchondroma of the thoracic spine: a rare case report and review of the literature. BMC Musculoskelet Disord. 2017 Apr 13. 18 (1):155. [QxMD MEDLINE Link]. [Full Text].
Bloem JL, Reidsma II. Bone and soft tissue tumors of hip and pelvis. Eur J Radiol. 2012 Dec. 81 (12):3793-801. [QxMD MEDLINE Link].
Shukla V, Agarwal A, Mittal G, Uppada UK, Rathi A. Enchondroma of the mandibular body: an occult entity. Ann Maxillofac Surg. 2020 Jan-Jun. 10 (1):272-4. [QxMD MEDLINE Link].
Walden MJ, Murphey MD, Vidal JA. Incidental enchondromas of the knee. AJR Am J Roentgenol. 2008 Jun. 190 (6):1611-5. [QxMD MEDLINE Link].
Kord A, Kravis B, Rsotami S, Pandhi M, Elbaz Younes I, Bauml J. Enchondroma protuberans of the hand: a case report. Radiol Case Rep. 2020 Jul. 15 (7):943-6. [QxMD MEDLINE Link].
Crim J, Schmidt R, Layfield L, Hanrahan C, Manaster BJ. Can imaging criteria distinguish enchondroma from grade 1 chondrosarcoma?. Eur J Radiol. 2015 Nov. 84 (11):2222-30. [QxMD MEDLINE Link].
Ghiasi MS, Chen J, Vaziri A, Rodriguez EK, Nazarian A. Bone fracture healing in mechanobiological modeling: A review of principles and methods. Bone Rep. 2017 Jun. 6:87-100. [QxMD MEDLINE Link].
Dhawan SB, Aggarwal R, Mohan H, Kumar S. Cytodiagnosis of enchondroma. Cytopathology. 2003 Jun. 14 (3):157-9. [QxMD MEDLINE Link].
Patro MK, Santosh T, Bal AK, Mishra B. Cytological diagnosis of enchondroma: report of three cases. Clin Cancer Investig J. 2017. 6 (6):258-60. [Full Text].
Sakai Junior N, Abe KT, Formigli LM, et al. Cytogenetic findings in 14 benign cartilaginous neoplasms. Cancer Genet. 2011 Apr. 204 (4):180-6. [QxMD MEDLINE Link].
van der Geest IC, de Valk MH, de Rooy JW, Pruszczynski M, Veth RP, Schreuder HW. Oncological and functional results of cryosurgical therapy of enchondromas and chondrosarcomas grade 1. J Surg Oncol. 2008 Nov 1. 98 (6):421-6. [QxMD MEDLINE Link].
Deckers C, Schreuder BH, Hannink G, de Rooy JW, van der Geest IC. Radiologic follow-up of untreated enchondroma and atypical cartilaginous tumors in the long bones. J Surg Oncol. 2016 Dec. 114 (8):987-91. [QxMD MEDLINE Link].